nodes	percent_of_prediction	percent_of_DWPC	metapath
Nalidixic Acid—SLC22A6—Chlorpropamide—type 2 diabetes mellitus	0.18	0.276	CbGbCtD
Nalidixic Acid—SLC22A6—Tolbutamide—type 2 diabetes mellitus	0.16	0.246	CbGbCtD
Nalidixic Acid—SLC22A6—Nateglinide—type 2 diabetes mellitus	0.136	0.209	CbGbCtD
Nalidixic Acid—SLC22A6—Glyburide—type 2 diabetes mellitus	0.0922	0.141	CbGbCtD
Nalidixic Acid—SLC22A6—Losartan—type 2 diabetes mellitus	0.0843	0.129	CbGbCtD
Nalidixic Acid—TDO2—Tryptophan metabolism—AANAT—type 2 diabetes mellitus	0.00707	0.116	CbGpPWpGaD
Nalidixic Acid—TDO2—Monoamine Transport—NOS1—type 2 diabetes mellitus	0.00312	0.051	CbGpPWpGaD
Nalidixic Acid—TDO2—Amino acid and derivative metabolism—BHMT—type 2 diabetes mellitus	0.00262	0.0429	CbGpPWpGaD
Nalidixic Acid—TDO2—Tryptophan metabolism—CYP2E1—type 2 diabetes mellitus	0.00239	0.0391	CbGpPWpGaD
Nalidixic Acid—TDO2—Tryptophan metabolism—CYP1A2—type 2 diabetes mellitus	0.00237	0.0387	CbGpPWpGaD
Nalidixic Acid—TDO2—Tryptophan metabolism—CYP3A4—type 2 diabetes mellitus	0.00231	0.0377	CbGpPWpGaD
Nalidixic Acid—TDO2—Amino acid and derivative metabolism—AANAT—type 2 diabetes mellitus	0.00229	0.0375	CbGpPWpGaD
Nalidixic Acid—TDO2—Amino acid and derivative metabolism—CDO1—type 2 diabetes mellitus	0.00217	0.0355	CbGpPWpGaD
Nalidixic Acid—TDO2—Monoamine Transport—AGT—type 2 diabetes mellitus	0.00204	0.0333	CbGpPWpGaD
Nalidixic Acid—TDO2—Tryptophan metabolism—CAT—type 2 diabetes mellitus	0.00192	0.0314	CbGpPWpGaD
Nalidixic Acid—TDO2—Amino acid and derivative metabolism—MAT1A—type 2 diabetes mellitus	0.00191	0.0313	CbGpPWpGaD
Nalidixic Acid—TDO2—Amino acid and derivative metabolism—CBS—type 2 diabetes mellitus	0.00151	0.0246	CbGpPWpGaD
Nalidixic Acid—Lomefloxacin—ABCC2—type 2 diabetes mellitus	0.00122	0.235	CrCbGaD
Nalidixic Acid—Pefloxacin—CYP1A2—type 2 diabetes mellitus	0.00115	0.221	CrCbGaD
Nalidixic Acid—Enoxacin—CYP1A2—type 2 diabetes mellitus	0.00107	0.207	CrCbGaD
Nalidixic Acid—TDO2—Amino acid and derivative metabolism—MTR—type 2 diabetes mellitus	0.000971	0.0159	CbGpPWpGaD
Nalidixic Acid—TDO2—Monoamine Transport—TNF—type 2 diabetes mellitus	0.000923	0.0151	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A4—type 2 diabetes mellitus	0.000863	0.0141	CbGpPWpGaD
Nalidixic Acid—TDO2—Amino acid and derivative metabolism—PSMD6—type 2 diabetes mellitus	0.000849	0.0139	CbGpPWpGaD
Nalidixic Acid—Lomefloxacin—CYP1A2—type 2 diabetes mellitus	0.000812	0.157	CrCbGaD
Nalidixic Acid—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A8—type 2 diabetes mellitus	0.00068	0.0111	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A2—type 2 diabetes mellitus	0.000654	0.0107	CbGpPWpGaD
Nalidixic Acid—SLC22A6—SLC-mediated transmembrane transport—SLC26A9—type 2 diabetes mellitus	0.000588	0.00961	CbGpPWpGaD
Nalidixic Acid—Rash—Nateglinide—type 2 diabetes mellitus	0.000572	0.00204	CcSEcCtD
Nalidixic Acid—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.000572	0.00204	CcSEcCtD
Nalidixic Acid—Photosensitivity reaction—Irbesartan—type 2 diabetes mellitus	0.000569	0.00203	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Pioglitazone—type 2 diabetes mellitus	0.000567	0.00202	CcSEcCtD
Nalidixic Acid—Norfloxacin—CYP1A2—type 2 diabetes mellitus	0.000563	0.109	CrCbGaD
Nalidixic Acid—Angioedema—Glyburide—type 2 diabetes mellitus	0.00056	0.002	CcSEcCtD
Nalidixic Acid—Nausea—Acarbose—type 2 diabetes mellitus	0.000559	0.002	CcSEcCtD
Nalidixic Acid—Pruritus—Repaglinide—type 2 diabetes mellitus	0.000556	0.00198	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Sitagliptin—type 2 diabetes mellitus	0.000551	0.00197	CcSEcCtD
Nalidixic Acid—Erythema—Gliclazide—type 2 diabetes mellitus	0.00055	0.00196	CcSEcCtD
Nalidixic Acid—Leukopenia—Glyburide—type 2 diabetes mellitus	0.000549	0.00196	CcSEcCtD
Nalidixic Acid—Paraesthesia—Glimepiride—type 2 diabetes mellitus	0.000545	0.00194	CcSEcCtD
Nalidixic Acid—Somnolence—Glimepiride—type 2 diabetes mellitus	0.000539	0.00192	CcSEcCtD
Nalidixic Acid—Nausea—Nateglinide—type 2 diabetes mellitus	0.000539	0.00192	CcSEcCtD
Nalidixic Acid—Somnolence—Sitagliptin—type 2 diabetes mellitus	0.000537	0.00192	CcSEcCtD
Nalidixic Acid—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.000537	0.00192	CcSEcCtD
Nalidixic Acid—Photosensitivity reaction—Losartan—type 2 diabetes mellitus	0.000536	0.00191	CcSEcCtD
Nalidixic Acid—Asthenia—Rosiglitazone—type 2 diabetes mellitus	0.000533	0.0019	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Glipizide—type 2 diabetes mellitus	0.000531	0.0019	CcSEcCtD
Nalidixic Acid—Convulsion—Glyburide—type 2 diabetes mellitus	0.000531	0.0019	CcSEcCtD
Nalidixic Acid—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.000525	0.00187	CcSEcCtD
Nalidixic Acid—Arthralgia—Glyburide—type 2 diabetes mellitus	0.000522	0.00186	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Losartan—type 2 diabetes mellitus	0.000519	0.00185	CcSEcCtD
Nalidixic Acid—Urticaria—Glipizide—type 2 diabetes mellitus	0.000516	0.00184	CcSEcCtD
Nalidixic Acid—Abdominal pain—Glipizide—type 2 diabetes mellitus	0.000514	0.00183	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Losartan—type 2 diabetes mellitus	0.000513	0.00183	CcSEcCtD
Nalidixic Acid—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000508	0.00181	CcSEcCtD
Nalidixic Acid—Angioedema—Gliclazide—type 2 diabetes mellitus	0.000503	0.00179	CcSEcCtD
Nalidixic Acid—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000499	0.00178	CcSEcCtD
Nalidixic Acid—Eosinophilia—Ramipril—type 2 diabetes mellitus	0.000498	0.00178	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Glimepiride—type 2 diabetes mellitus	0.000496	0.00177	CcSEcCtD
Nalidixic Acid—Rash—Repaglinide—type 2 diabetes mellitus	0.000495	0.00177	CcSEcCtD
Nalidixic Acid—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000495	0.00177	CcSEcCtD
Nalidixic Acid—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.000495	0.00177	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Sitagliptin—type 2 diabetes mellitus	0.000494	0.00176	CcSEcCtD
Nalidixic Acid—Leukopenia—Gliclazide—type 2 diabetes mellitus	0.000493	0.00176	CcSEcCtD
Nalidixic Acid—Headache—Repaglinide—type 2 diabetes mellitus	0.000492	0.00176	CcSEcCtD
Nalidixic Acid—Paraesthesia—Bromocriptine—type 2 diabetes mellitus	0.000491	0.00175	CcSEcCtD
Nalidixic Acid—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000491	0.00175	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Glyburide—type 2 diabetes mellitus	0.00049	0.00175	CcSEcCtD
Nalidixic Acid—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.000486	0.00174	CcSEcCtD
Nalidixic Acid—Urticaria—Glimepiride—type 2 diabetes mellitus	0.000482	0.00172	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—BHMT—type 2 diabetes mellitus	0.000482	0.00787	CbGpPWpGaD
Nalidixic Acid—Visual impairment—Irbesartan—type 2 diabetes mellitus	0.000481	0.00172	CcSEcCtD
Nalidixic Acid—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.00048	0.00171	CcSEcCtD
Nalidixic Acid—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.000479	0.00171	CcSEcCtD
Nalidixic Acid—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.000478	0.00171	CcSEcCtD
Nalidixic Acid—Convulsion—Gliclazide—type 2 diabetes mellitus	0.000477	0.0017	CcSEcCtD
Nalidixic Acid—Arthralgia—Gliclazide—type 2 diabetes mellitus	0.000468	0.00167	CcSEcCtD
Nalidixic Acid—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000468	0.00167	CcSEcCtD
Nalidixic Acid—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000468	0.00167	CcSEcCtD
Nalidixic Acid—Nausea—Repaglinide—type 2 diabetes mellitus	0.000467	0.00167	CcSEcCtD
Nalidixic Acid—Asthenia—Glipizide—type 2 diabetes mellitus	0.000466	0.00166	CcSEcCtD
Nalidixic Acid—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000465	0.00166	CcSEcCtD
Nalidixic Acid—Angioedema—Valsartan—type 2 diabetes mellitus	0.000462	0.00165	CcSEcCtD
Nalidixic Acid—Erythema—Metformin—type 2 diabetes mellitus	0.00046	0.00164	CcSEcCtD
Nalidixic Acid—Pruritus—Glipizide—type 2 diabetes mellitus	0.00046	0.00164	CcSEcCtD
Nalidixic Acid—Photosensitivity reaction—Ramipril—type 2 diabetes mellitus	0.000459	0.00164	CcSEcCtD
Nalidixic Acid—Angioedema—Orlistat—type 2 diabetes mellitus	0.000456	0.00163	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	0.000456	0.00163	CcSEcCtD
Nalidixic Acid—Vertigo—Valsartan—type 2 diabetes mellitus	0.000454	0.00162	CcSEcCtD
Nalidixic Acid—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.000449	0.0016	CcSEcCtD
Nalidixic Acid—Vertigo—Orlistat—type 2 diabetes mellitus	0.000449	0.0016	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000447	0.0016	CcSEcCtD
Nalidixic Acid—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—type 2 diabetes mellitus	0.000447	0.0073	CbGpPWpGaD
Nalidixic Acid—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000447	0.00159	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Ramipril—type 2 diabetes mellitus	0.000445	0.00159	CcSEcCtD
Nalidixic Acid—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000445	0.00159	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Losartan—type 2 diabetes mellitus	0.000444	0.00159	CcSEcCtD
Nalidixic Acid—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000441	0.00157	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Ramipril—type 2 diabetes mellitus	0.00044	0.00157	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.00044	0.00157	CcSEcCtD
Nalidixic Acid—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000435	0.00155	CcSEcCtD
Nalidixic Acid—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000435	0.00155	CcSEcCtD
Nalidixic Acid—Erythema—Irbesartan—type 2 diabetes mellitus	0.000434	0.00155	CcSEcCtD
Nalidixic Acid—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000434	0.00155	CcSEcCtD
Nalidixic Acid—Convulsion—Orlistat—type 2 diabetes mellitus	0.000433	0.00154	CcSEcCtD
Nalidixic Acid—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000433	0.00154	CcSEcCtD
Nalidixic Acid—Arthralgia—Valsartan—type 2 diabetes mellitus	0.00043	0.00154	CcSEcCtD
Nalidixic Acid—Dizziness—Glipizide—type 2 diabetes mellitus	0.00043	0.00153	CcSEcCtD
Nalidixic Acid—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000429	0.00153	CcSEcCtD
Nalidixic Acid—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000426	0.00152	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—PTGDS—type 2 diabetes mellitus	0.000421	0.00688	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—AANAT—type 2 diabetes mellitus	0.000421	0.00688	CbGpPWpGaD
Nalidixic Acid—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000415	0.00148	CcSEcCtD
Nalidixic Acid—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000414	0.00148	CcSEcCtD
Nalidixic Acid—Vomiting—Glipizide—type 2 diabetes mellitus	0.000413	0.00147	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000413	0.00147	CcSEcCtD
Nalidixic Acid—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000412	0.00147	CcSEcCtD
Nalidixic Acid—Rash—Glipizide—type 2 diabetes mellitus	0.00041	0.00146	CcSEcCtD
Nalidixic Acid—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000409	0.00146	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000409	0.00146	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000409	0.00146	CcSEcCtD
Nalidixic Acid—Erythema—Losartan—type 2 diabetes mellitus	0.000409	0.00146	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000408	0.00146	CcSEcCtD
Nalidixic Acid—Headache—Glipizide—type 2 diabetes mellitus	0.000407	0.00145	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000404	0.00144	CcSEcCtD
Nalidixic Acid—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000403	0.00144	CcSEcCtD
Nalidixic Acid—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000401	0.00143	CcSEcCtD
Nalidixic Acid—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.0004	0.00143	CcSEcCtD
Nalidixic Acid—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000399	0.00142	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—CDO1—type 2 diabetes mellitus	0.000399	0.00652	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—GPD2—type 2 diabetes mellitus	0.000399	0.00652	CbGpPWpGaD
Nalidixic Acid—Urticaria—Glyburide—type 2 diabetes mellitus	0.000397	0.00142	CcSEcCtD
Nalidixic Acid—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000397	0.00142	CcSEcCtD
Nalidixic Acid—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000395	0.00141	CcSEcCtD
Nalidixic Acid—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000393	0.0014	CcSEcCtD
Nalidixic Acid—SLC22A6—SLC-mediated transmembrane transport—SLC5A4—type 2 diabetes mellitus	0.000392	0.00641	CbGpPWpGaD
Nalidixic Acid—Vertigo—Irbesartan—type 2 diabetes mellitus	0.00039	0.00139	CcSEcCtD
Nalidixic Acid—Headache—Pioglitazone—type 2 diabetes mellitus	0.00039	0.00139	CcSEcCtD
Nalidixic Acid—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000389	0.00139	CcSEcCtD
Nalidixic Acid—Visual impairment—Ramipril—type 2 diabetes mellitus	0.000388	0.00139	CcSEcCtD
Nalidixic Acid—Nausea—Glipizide—type 2 diabetes mellitus	0.000386	0.00138	CcSEcCtD
Nalidixic Acid—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000386	0.00138	CcSEcCtD
Nalidixic Acid—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000384	0.00137	CcSEcCtD
Nalidixic Acid—Rash—Glimepiride—type 2 diabetes mellitus	0.000382	0.00136	CcSEcCtD
Nalidixic Acid—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000382	0.00136	CcSEcCtD
Nalidixic Acid—Rash—Sitagliptin—type 2 diabetes mellitus	0.000381	0.00136	CcSEcCtD
Nalidixic Acid—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000381	0.00136	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000381	0.00136	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—AK1—type 2 diabetes mellitus	0.000381	0.00622	CbGpPWpGaD
Nalidixic Acid—Headache—Glimepiride—type 2 diabetes mellitus	0.00038	0.00136	CcSEcCtD
Nalidixic Acid—SLC22A6—SLC-mediated transmembrane transport—G6PC—type 2 diabetes mellitus	0.000379	0.00619	CbGpPWpGaD
Nalidixic Acid—Headache—Sitagliptin—type 2 diabetes mellitus	0.000379	0.00135	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000376	0.00134	CcSEcCtD
Nalidixic Acid—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000374	0.00134	CcSEcCtD
Nalidixic Acid—Angioedema—Losartan—type 2 diabetes mellitus	0.000374	0.00133	CcSEcCtD
Nalidixic Acid—Norfloxacin—CYP3A4—type 2 diabetes mellitus	0.000373	0.0719	CrCbGaD
Nalidixic Acid—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000371	0.00133	CcSEcCtD
Nalidixic Acid—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000371	0.00132	CcSEcCtD
Nalidixic Acid—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.00037	0.00132	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000368	0.00131	CcSEcCtD
Nalidixic Acid—Vertigo—Losartan—type 2 diabetes mellitus	0.000367	0.00131	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000367	0.00131	CcSEcCtD
Nalidixic Acid—Somnolence—Valsartan—type 2 diabetes mellitus	0.000367	0.00131	CcSEcCtD
Nalidixic Acid—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000366	0.00131	CcSEcCtD
Nalidixic Acid—Leukopenia—Losartan—type 2 diabetes mellitus	0.000366	0.00131	CcSEcCtD
Nalidixic Acid—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000362	0.00129	CcSEcCtD
Nalidixic Acid—Nausea—Glimepiride—type 2 diabetes mellitus	0.00036	0.00129	CcSEcCtD
Nalidixic Acid—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000359	0.00128	CcSEcCtD
Nalidixic Acid—Asthenia—Glyburide—type 2 diabetes mellitus	0.000359	0.00128	CcSEcCtD
Nalidixic Acid—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000357	0.00127	CcSEcCtD
Nalidixic Acid—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000355	0.00127	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000355	0.00127	CcSEcCtD
Nalidixic Acid—Pruritus—Glyburide—type 2 diabetes mellitus	0.000354	0.00126	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—MAT1A—type 2 diabetes mellitus	0.000351	0.00574	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—SLC5A4—type 2 diabetes mellitus	0.000351	0.00574	CbGpPWpGaD
Nalidixic Acid—Erythema—Ramipril—type 2 diabetes mellitus	0.000351	0.00125	CcSEcCtD
Nalidixic Acid—Arthralgia—Losartan—type 2 diabetes mellitus	0.000348	0.00124	CcSEcCtD
Nalidixic Acid—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000348	0.00124	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000347	0.00124	CcSEcCtD
Nalidixic Acid—Rash—Bromocriptine—type 2 diabetes mellitus	0.000345	0.00123	CcSEcCtD
Nalidixic Acid—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000345	0.00123	CcSEcCtD
Nalidixic Acid—Headache—Bromocriptine—type 2 diabetes mellitus	0.000343	0.00122	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000342	0.00122	CcSEcCtD
Nalidixic Acid—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000342	0.00122	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—HBA2—type 2 diabetes mellitus	0.000339	0.00555	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—PPP1R3C—type 2 diabetes mellitus	0.000339	0.00555	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—ENPP1—type 2 diabetes mellitus	0.000339	0.00555	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—ND1—type 2 diabetes mellitus	0.000339	0.00555	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—G6PC—type 2 diabetes mellitus	0.000339	0.00555	CbGpPWpGaD
Nalidixic Acid—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000337	0.0012	CcSEcCtD
Nalidixic Acid—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000337	0.0012	CcSEcCtD
Nalidixic Acid—Somnolence—Metformin—type 2 diabetes mellitus	0.000334	0.00119	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000334	0.00119	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000333	0.00119	CcSEcCtD
Nalidixic Acid—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A4—type 2 diabetes mellitus	0.000332	0.00542	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—GCGR—type 2 diabetes mellitus	0.000329	0.00537	CbGpPWpGaD
Nalidixic Acid—Urticaria—Valsartan—type 2 diabetes mellitus	0.000328	0.00117	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000327	0.00117	CcSEcCtD
Nalidixic Acid—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000326	0.00116	CcSEcCtD
Nalidixic Acid—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000325	0.00116	CcSEcCtD
Nalidixic Acid—Urticaria—Orlistat—type 2 diabetes mellitus	0.000324	0.00116	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000323	0.00115	CcSEcCtD
Nalidixic Acid—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000322	0.00115	CcSEcCtD
Nalidixic Acid—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000322	0.00115	CcSEcCtD
Nalidixic Acid—Angioedema—Ramipril—type 2 diabetes mellitus	0.00032	0.00114	CcSEcCtD
Nalidixic Acid—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000318	0.00114	CcSEcCtD
Nalidixic Acid—Vomiting—Glyburide—type 2 diabetes mellitus	0.000318	0.00113	CcSEcCtD
Nalidixic Acid—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000318	0.00113	CcSEcCtD
Nalidixic Acid—Rash—Glyburide—type 2 diabetes mellitus	0.000315	0.00113	CcSEcCtD
Nalidixic Acid—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000315	0.00113	CcSEcCtD
Nalidixic Acid—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000315	0.00112	CcSEcCtD
Nalidixic Acid—Vertigo—Ramipril—type 2 diabetes mellitus	0.000315	0.00112	CcSEcCtD
Nalidixic Acid—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000314	0.00112	CcSEcCtD
Nalidixic Acid—Headache—Glyburide—type 2 diabetes mellitus	0.000313	0.00112	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—CYTB—type 2 diabetes mellitus	0.00031	0.00507	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—OXCT1—type 2 diabetes mellitus	0.00031	0.00507	CbGpPWpGaD
Nalidixic Acid—SLC22A6—SLC-mediated transmembrane transport—SLC30A8—type 2 diabetes mellitus	0.000309	0.00505	CbGpPWpGaD
Nalidixic Acid—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000307	0.0011	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000307	0.0011	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000304	0.00109	CcSEcCtD
Nalidixic Acid—Convulsion—Ramipril—type 2 diabetes mellitus	0.000304	0.00108	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—SRD5A1—type 2 diabetes mellitus	0.000303	0.00494	CbGpPWpGaD
Nalidixic Acid—Paraesthesia—Losartan—type 2 diabetes mellitus	0.0003	0.00107	CcSEcCtD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	0.000299	0.00488	CbGpPWpGaD
Nalidixic Acid—Urticaria—Metformin—type 2 diabetes mellitus	0.000299	0.00107	CcSEcCtD
Nalidixic Acid—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000298	0.00107	CcSEcCtD
Nalidixic Acid—SLC22A6—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	0.000297	0.00486	CbGpPWpGaD
Nalidixic Acid—Nausea—Glyburide—type 2 diabetes mellitus	0.000297	0.00106	CcSEcCtD
Nalidixic Acid—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000297	0.00106	CcSEcCtD
Nalidixic Acid—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000297	0.00106	CcSEcCtD
Nalidixic Acid—Somnolence—Losartan—type 2 diabetes mellitus	0.000297	0.00106	CcSEcCtD
Nalidixic Acid—Asthenia—Valsartan—type 2 diabetes mellitus	0.000296	0.00106	CcSEcCtD
Nalidixic Acid—Asthenia—Orlistat—type 2 diabetes mellitus	0.000293	0.00104	CcSEcCtD
Nalidixic Acid—Pruritus—Valsartan—type 2 diabetes mellitus	0.000292	0.00104	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.00029	0.00103	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—ACACA—type 2 diabetes mellitus	0.000289	0.00472	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—HSD17B3—type 2 diabetes mellitus	0.000289	0.00472	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—STAR—type 2 diabetes mellitus	0.000289	0.00472	CbGpPWpGaD
Nalidixic Acid—Pruritus—Orlistat—type 2 diabetes mellitus	0.000288	0.00103	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000286	0.00102	CcSEcCtD
Nalidixic Acid—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000286	0.00102	CcSEcCtD
Nalidixic Acid—Rash—Gliclazide—type 2 diabetes mellitus	0.000283	0.00101	CcSEcCtD
Nalidixic Acid—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000283	0.00101	CcSEcCtD
Nalidixic Acid—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000282	0.00101	CcSEcCtD
Nalidixic Acid—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000282	0.00101	CcSEcCtD
Nalidixic Acid—Headache—Gliclazide—type 2 diabetes mellitus	0.000281	0.001	CcSEcCtD
Nalidixic Acid—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.00028	0.001	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.00028	0.001	CcSEcCtD
Nalidixic Acid—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000279	0.000996	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—CBS—type 2 diabetes mellitus	0.000277	0.00452	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—ABCC8—type 2 diabetes mellitus	0.000277	0.00452	CbGpPWpGaD
Nalidixic Acid—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000273	0.000974	CcSEcCtD
Nalidixic Acid—Dizziness—Valsartan—type 2 diabetes mellitus	0.000273	0.000974	CcSEcCtD
Nalidixic Acid—Dizziness—Orlistat—type 2 diabetes mellitus	0.00027	0.000962	CcSEcCtD
Nalidixic Acid—Asthenia—Metformin—type 2 diabetes mellitus	0.00027	0.000962	CcSEcCtD
Nalidixic Acid—Nausea—Gliclazide—type 2 diabetes mellitus	0.000267	0.000952	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—SLC5A2—type 2 diabetes mellitus	0.000266	0.00435	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—COX2—type 2 diabetes mellitus	0.000266	0.00435	CbGpPWpGaD
Nalidixic Acid—Pruritus—Metformin—type 2 diabetes mellitus	0.000266	0.000949	CcSEcCtD
Nalidixic Acid—Urticaria—Losartan—type 2 diabetes mellitus	0.000265	0.000946	CcSEcCtD
Nalidixic Acid—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000264	0.000942	CcSEcCtD
Nalidixic Acid—Vomiting—Valsartan—type 2 diabetes mellitus	0.000262	0.000936	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—NCOA6—type 2 diabetes mellitus	0.000262	0.00428	CbGpPWpGaD
Nalidixic Acid—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000261	0.00093	CcSEcCtD
Nalidixic Acid—Rash—Valsartan—type 2 diabetes mellitus	0.00026	0.000929	CcSEcCtD
Nalidixic Acid—Dermatitis—Valsartan—type 2 diabetes mellitus	0.00026	0.000928	CcSEcCtD
Nalidixic Acid—Vomiting—Orlistat—type 2 diabetes mellitus	0.000259	0.000925	CcSEcCtD
Nalidixic Acid—Headache—Valsartan—type 2 diabetes mellitus	0.000258	0.000923	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—UCP3—type 2 diabetes mellitus	0.000257	0.0042	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—HSD11B1—type 2 diabetes mellitus	0.000257	0.0042	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—UCP2—type 2 diabetes mellitus	0.000257	0.0042	CbGpPWpGaD
Nalidixic Acid—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000257	0.000918	CcSEcCtD
Nalidixic Acid—Rash—Orlistat—type 2 diabetes mellitus	0.000257	0.000917	CcSEcCtD
Nalidixic Acid—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000257	0.000917	CcSEcCtD
Nalidixic Acid—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000257	0.000917	CcSEcCtD
Nalidixic Acid—Headache—Orlistat—type 2 diabetes mellitus	0.000255	0.000912	CcSEcCtD
Nalidixic Acid—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000254	0.000908	CcSEcCtD
Nalidixic Acid—Somnolence—Ramipril—type 2 diabetes mellitus	0.000254	0.000908	CcSEcCtD
Nalidixic Acid—SLC22A6—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	0.000253	0.00413	CbGpPWpGaD
Nalidixic Acid—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000251	0.000895	CcSEcCtD
Nalidixic Acid—Dizziness—Metformin—type 2 diabetes mellitus	0.000248	0.000887	CcSEcCtD
Nalidixic Acid—Nausea—Valsartan—type 2 diabetes mellitus	0.000245	0.000875	CcSEcCtD
Nalidixic Acid—SLC22A6—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	0.000244	0.00399	CbGpPWpGaD
Nalidixic Acid—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000243	0.000866	CcSEcCtD
Nalidixic Acid—Nausea—Orlistat—type 2 diabetes mellitus	0.000242	0.000864	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—PCK1—type 2 diabetes mellitus	0.000242	0.00395	CbGpPWpGaD
Nalidixic Acid—Asthenia—Losartan—type 2 diabetes mellitus	0.000239	0.000855	CcSEcCtD
Nalidixic Acid—Vomiting—Metformin—type 2 diabetes mellitus	0.000239	0.000853	CcSEcCtD
Nalidixic Acid—Rash—Metformin—type 2 diabetes mellitus	0.000237	0.000846	CcSEcCtD
Nalidixic Acid—Dermatitis—Metformin—type 2 diabetes mellitus	0.000237	0.000845	CcSEcCtD
Nalidixic Acid—Pruritus—Losartan—type 2 diabetes mellitus	0.000236	0.000843	CcSEcCtD
Nalidixic Acid—Headache—Metformin—type 2 diabetes mellitus	0.000235	0.00084	CcSEcCtD
Nalidixic Acid—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000234	0.000837	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000234	0.000835	CcSEcCtD
Nalidixic Acid—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000228	0.000815	CcSEcCtD
Nalidixic Acid—Urticaria—Ramipril—type 2 diabetes mellitus	0.000227	0.000811	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—HK1—type 2 diabetes mellitus	0.000226	0.0037	CbGpPWpGaD
Nalidixic Acid—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000226	0.000807	CcSEcCtD
Nalidixic Acid—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000225	0.000805	CcSEcCtD
Nalidixic Acid—Rash—Irbesartan—type 2 diabetes mellitus	0.000224	0.000798	CcSEcCtD
Nalidixic Acid—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000223	0.000797	CcSEcCtD
Nalidixic Acid—Nausea—Metformin—type 2 diabetes mellitus	0.000223	0.000797	CcSEcCtD
Nalidixic Acid—Headache—Irbesartan—type 2 diabetes mellitus	0.000222	0.000793	CcSEcCtD
Nalidixic Acid—Dizziness—Losartan—type 2 diabetes mellitus	0.000221	0.000788	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—HSD3B2—type 2 diabetes mellitus	0.000219	0.00357	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—KCNJ11—type 2 diabetes mellitus	0.000219	0.00357	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—GCKR—type 2 diabetes mellitus	0.000219	0.00357	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—LPA—type 2 diabetes mellitus	0.000219	0.00357	CbGpPWpGaD
Nalidixic Acid—Vomiting—Losartan—type 2 diabetes mellitus	0.000212	0.000757	CcSEcCtD
Nalidixic Acid—Nausea—Irbesartan—type 2 diabetes mellitus	0.000211	0.000752	CcSEcCtD
Nalidixic Acid—Rash—Losartan—type 2 diabetes mellitus	0.00021	0.000751	CcSEcCtD
Nalidixic Acid—Dermatitis—Losartan—type 2 diabetes mellitus	0.00021	0.00075	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—ALDOB—type 2 diabetes mellitus	0.00021	0.00343	CbGpPWpGaD
Nalidixic Acid—Headache—Losartan—type 2 diabetes mellitus	0.000209	0.000746	CcSEcCtD
Nalidixic Acid—Asthenia—Ramipril—type 2 diabetes mellitus	0.000205	0.000733	CcSEcCtD
Nalidixic Acid—SLC22A6—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	0.000203	0.00332	CbGpPWpGaD
Nalidixic Acid—Pruritus—Ramipril—type 2 diabetes mellitus	0.000202	0.000723	CcSEcCtD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	0.000199	0.00326	CbGpPWpGaD
Nalidixic Acid—Nausea—Losartan—type 2 diabetes mellitus	0.000198	0.000707	CcSEcCtD
Nalidixic Acid—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000196	0.000699	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—GLP1R—type 2 diabetes mellitus	0.000195	0.00319	CbGpPWpGaD
Nalidixic Acid—SLC22A6—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	0.000194	0.00317	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	0.000192	0.00315	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	0.000192	0.00315	CbGpPWpGaD
Nalidixic Acid—SLC22A6—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	0.000189	0.00309	CbGpPWpGaD
Nalidixic Acid—Dizziness—Ramipril—type 2 diabetes mellitus	0.000189	0.000675	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—SLC2A2—type 2 diabetes mellitus	0.000182	0.00297	CbGpPWpGaD
Nalidixic Acid—Vomiting—Ramipril—type 2 diabetes mellitus	0.000182	0.000649	CcSEcCtD
Nalidixic Acid—Rash—Ramipril—type 2 diabetes mellitus	0.00018	0.000644	CcSEcCtD
Nalidixic Acid—Dermatitis—Ramipril—type 2 diabetes mellitus	0.00018	0.000643	CcSEcCtD
Nalidixic Acid—Headache—Ramipril—type 2 diabetes mellitus	0.000179	0.00064	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—MTR—type 2 diabetes mellitus	0.000178	0.00291	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—CPT1A—type 2 diabetes mellitus	0.000178	0.00291	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	0.000176	0.00288	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—NAMPT—type 2 diabetes mellitus	0.000175	0.00286	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—GCK—type 2 diabetes mellitus	0.000174	0.00284	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—HBA1—type 2 diabetes mellitus	0.000174	0.00284	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—LIPC—type 2 diabetes mellitus	0.000174	0.00284	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—CYP11A1—type 2 diabetes mellitus	0.000173	0.00282	CbGpPWpGaD
Nalidixic Acid—Nausea—Ramipril—type 2 diabetes mellitus	0.00017	0.000607	CcSEcCtD
Nalidixic Acid—TDO2—Metabolism—SLC9A1—type 2 diabetes mellitus	0.00017	0.00277	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—CETP—type 2 diabetes mellitus	0.000168	0.00274	CbGpPWpGaD
Nalidixic Acid—SLC22A6—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	0.000157	0.00257	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	0.000157	0.00256	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	0.000157	0.00256	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—PSMD6—type 2 diabetes mellitus	0.000156	0.00255	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—SREBF1—type 2 diabetes mellitus	0.000156	0.00255	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—SNAP25—type 2 diabetes mellitus	0.000156	0.00255	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—CTGF—type 2 diabetes mellitus	0.000153	0.0025	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—HMGCR—type 2 diabetes mellitus	0.000152	0.00248	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	0.000151	0.00247	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	0.000151	0.00247	CbGpPWpGaD
Nalidixic Acid—SLC22A6—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	0.000151	0.00246	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	0.000148	0.00242	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—ADRA2A—type 2 diabetes mellitus	0.000148	0.00242	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—CYP2E1—type 2 diabetes mellitus	0.000143	0.00233	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—SLC2A1—type 2 diabetes mellitus	0.000141	0.0023	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—CYP1A2—type 2 diabetes mellitus	0.000141	0.0023	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—CYP3A4—type 2 diabetes mellitus	0.000137	0.00225	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	0.000137	0.00224	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—SLC2A4—type 2 diabetes mellitus	0.000135	0.00221	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—GCG—type 2 diabetes mellitus	0.000135	0.00221	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	0.000128	0.0021	CbGpPWpGaD
Nalidixic Acid—SLC22A6—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	0.000128	0.0021	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	0.000124	0.00203	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	0.000119	0.00194	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—PPARGC1A—type 2 diabetes mellitus	0.000116	0.0019	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—GNB3—type 2 diabetes mellitus	0.000116	0.0019	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—HMOX1—type 2 diabetes mellitus	0.000116	0.00189	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—CAT—type 2 diabetes mellitus	0.000114	0.00187	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—APOB—type 2 diabetes mellitus	0.000111	0.00181	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—GSTM1—type 2 diabetes mellitus	0.000108	0.00177	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—LPL—type 2 diabetes mellitus	0.000106	0.00173	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—ADCY5—type 2 diabetes mellitus	0.000104	0.0017	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—GPX1—type 2 diabetes mellitus	0.000103	0.00169	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	0.000103	0.00169	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—CD36—type 2 diabetes mellitus	0.000101	0.00165	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—PPP2CA—type 2 diabetes mellitus	9.95e-05	0.00163	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	9.85e-05	0.00161	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	9.85e-05	0.00161	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	9.62e-05	0.00157	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	9.56e-05	0.00156	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—MTHFR—type 2 diabetes mellitus	9.55e-05	0.00156	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	9.51e-05	0.00155	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—PPARA—type 2 diabetes mellitus	9.37e-05	0.00153	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—AGT—type 2 diabetes mellitus	9.07e-05	0.00148	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—CALM1—type 2 diabetes mellitus	8.92e-05	0.00146	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—APOE—type 2 diabetes mellitus	8.89e-05	0.00145	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—APOA1—type 2 diabetes mellitus	8.79e-05	0.00144	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	8.38e-05	0.00137	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	7.99e-05	0.00131	CbGpPWpGaD
Nalidixic Acid—SLC22A6—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	7.77e-05	0.00127	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—PPARG—type 2 diabetes mellitus	7.74e-05	0.00126	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	7.66e-05	0.00125	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—INS—type 2 diabetes mellitus	7.59e-05	0.00124	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—ALB—type 2 diabetes mellitus	6.96e-05	0.00114	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—NOS3—type 2 diabetes mellitus	6.66e-05	0.00109	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—PIK3R1—type 2 diabetes mellitus	6.66e-05	0.00109	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	6.6e-05	0.00108	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	6.57e-05	0.00107	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	6.52e-05	0.00106	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	6.3e-05	0.00103	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—PTGS2—type 2 diabetes mellitus	6.09e-05	0.000995	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	5.89e-05	0.000962	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	5.31e-05	0.000868	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	4.98e-05	0.000814	CbGpPWpGaD
Nalidixic Acid—SLC22A6—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	3.95e-05	0.000645	CbGpPWpGaD
Nalidixic Acid—TDO2—Metabolism—AKT1—type 2 diabetes mellitus	3.06e-05	0.0005	CbGpPWpGaD
